Xenon Pharmaceuticals (XENE) Other Accumulated Expenses (2013 - 2025)

Xenon Pharmaceuticals (XENE) has 13 years of Other Accumulated Expenses data on file, last reported at $966000.0 in Q4 2025.

• On a quarterly basis, Other Accumulated Expenses rose 35.29% year-over-year to $966000.0 in Q4 2025; TTM through Dec 2025 was $966000.0, a 35.29% increase from a year earlier, with the FY2025 full-year figure at $966000.0, up 35.29% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $966000.0, up from $935000.0 in the prior quarter.
• Over the last five years, Other Accumulated Expenses for XENE reached as high as $1.1 million in Q2 2024 and fell as low as $26000.0 in Q3 2021.
• Historically, Other Accumulated Expenses has averaged $418842.1 across 5 years, with a median of $282000.0 in 2022.
• On a YoY basis, Other Accumulated Expenses climbed as much as 1106.59% in 2024 and fell as far as 86.13% in 2024.
• Year by year, Other Accumulated Expenses stood at $118000.0 in 2021, then soared by 188.98% to $341000.0 in 2022, then sank by 68.62% to $107000.0 in 2023, then surged by 567.29% to $714000.0 in 2024, then surged by 35.29% to $966000.0 in 2025.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $966000.0 in Q4 2025, $935000.0 in Q3 2025, and $439000.0 in Q2 2025.